Amenorrhea is the absence of menstrual periods and is divided into primary and secondary types. Primary amenorrhea refers to the absence of periods by age 14 with no sexual development, or by age 16 with normal development. Secondary amenorrhea is defined as missing periods for 3 cycles or 6 months in women who previously menstruated regularly. Potential causes include pregnancy, breastfeeding, medical conditions, eating disorders, excessive exercise, and medications. Diagnosis involves medical history, physical exam, and lab tests. Treatment focuses on addressing the underlying cause through lifestyle changes, medication, surgery, or hormone therapy. Nurses educate and counsel patients, and emphasize healthy lifestyle behaviors.
Amenorrhea Presented By Muhammad Abdullah.pptxEmma269971
Amenorrhea is the absence of menstrual periods in women of reproductive age. It can be a sign of underlying health issues and can have significant impacts on a woman's fertility and overall health. In this PPT, you will learn about the definition, types, and causes of amenorrhea, including primary and secondary amenorrhea.
The presentation will cover the financial impact of amenorrhea on women's health, as well as the common symptoms and clinical findings associated with this condition. Additionally, the PPT will explore the differential diagnosis of amenorrhea, which involves ruling out other potential causes of menstrual irregularities, such as pregnancy, thyroid disorders, and polycystic ovary syndrome (PCOS).
The PPT will also delve into the treatment and management of amenorrhea, including lifestyle changes, hormone therapy, and surgical interventions. Furthermore, the presentation will discuss the crucial role of pharmacies in providing support and advice to women with amenorrhea, such as providing access to medications and monitoring treatment efficacy.
Overall, this PPT will provide a comprehensive overview of amenorrhea, from its definition and symptoms to its diagnosis, treatment, and management, highlighting the critical role of healthcare professionals, including pharmacists, in helping women with this condition.
Menopause is signaled by 12 months since last menstruation.
Common symptoms include hot flashes and vaginal dryness. There may also be sleep disturbances. The combination of these symptoms can cause anxiety or depression.
Menopause is a natural process with treatments that focus on symptomatic relief. Vaginal dryness is treated with topical lubricants or estrogen. Medications can reduce the severity and frequency of hot flushes. In special circumstances, oral hormone therapy may be used.
menstrual manipulation for adolescents with disabilityMini Sood
A presentation of aspects of menstrual care in adolescents including those with disability. Slides for medical students who may encounter young patients who are unable to mange their menses efficiently
Men and women can both be infertile, and the cause of infertility varies in women and men. For women, the cause of infertility ranges from diseases of the thyroid to fibroids in the uterus and even endometriosis.
@women health , #menopause ,#DEFINITION OF MENOPAUSE
● @STAGES OF MENOPAUSE
● #MENOPAUSAL SYMPTOMS
● @TREATMENT OPTIONS
12 months of amenorrhea
without any other obvious
pathological cause or
physiological cause.
Why menopause
occurs in old women?
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
2. Amenorrhea
Amenorrhea is a term describing the
absence of a woman’s menstrual period
during the age when the woman is
reproductive.
Note: Pregnancy and lactation can cause
Amenorrhea.
Menstrual Disorders: Amenorrhea | Page 2
3. Amenorrhea: The definition
Amenorrhea is divided into two categories:
1. Primary amenorrhea
2. Secondary amenorrhea
Menstrual Disorders: Amenorrhea | Page 3
4. Amenorrhea: The definition
Primary amenorrhea is:
the absence of menses (blood and discharge from the
uterus) by 14 years of age. Additionally, primary
amenorrhea includes the absence of secondary sexual
chch growth and development.
the absence of menses by 16 years of age with normal
secondary sexual chch growth and development
Menstrual Disorders: Amenorrhea | Page 4
5. Amenorrhea: The definition
Secondary amenorrhea is:
• The absence of menses for 3 cycles or six
months in women who have previously
menstruated regularly
Menstrual Disorders: Amenorrhea | Page 5
6. Amenorrhea: Causes
Primary amenorrhea causes are:
Extreme weight gain
Congenial abnormalities of the reproductive
system
Stress
Excessive exercise
Eating disorders
Polycystic ovarian syndrome
Hypothyroidism
Turner Syndrome
Imperforated Hymen
Chronic illness
Pregnancy
Cystic fibrosis
Congenial heart disease
Ovarian or adrenal tumors
Menstrual Disorders: Amenorrhea | Page 6
7. Amenorrhea: Causes
Secondary amenorrhea causes are:
Breast feeding
Emotional stress
Malnutrition
Pituitary, ovarian, or adrenal tumours
Depression
Pregnancy
Hyper thyroid or hypothermia
Hyper prolactinemia
Rapid weight gain or loss
Chemotherapy or radiotherapy
Vigorous excrete
Kidney failure
Colitis
Tranquilizers or antidepressants
Post partum pituitary necrosis
Early menopause
Menstrual Disorders: Amenorrhea | Page 7
8. Amenorrhea: Assessment
A medical assessments should include:
History of etiologic factors
Physical examination for:
Nutritional status
Weights, height and vital signs
Signs of eating disorder (hypothermia, bradycardia, hypertension, and reduced
subcutaneous fat)
Androgen excess e.g. facial hair and acne
Delayed puberty: absence of facial hair and axillary hair
Laboratory tests for:
U/S
Pregnancy test
Thyroid function test
Prolactine levels
If high level FSH: indicate ovarian failure
If high level of LH: indicate gonadal dysfunction
Leprascopy
CT
Menstrual Disorders: Amenorrhea | Page 8
9. Amenorrhea: Treatment
To treat Primary amenorrhea:
Correct the underlying causes
Oestrogen replacement therapy
If pituitary tumour: treatment with surgical
resection, radiation and drug therapy
Surgery to correct abnormalities of genital tract
Menstrual Disorders: Amenorrhea | Page 9
10. Amenorrhea: Treatment
To treat secondary amenorrhea:
Cyclic progesterone
Promocriptime to treat hyperprolactinemia
GnRH: when the cause is hypeothalamic failure
Thyroid hormone replacement
Menstrual Disorders: Amenorrhea | Page 10
11. Amenorrhea: Nursing
Intervention
Nurses will:
counsel and educate patients
address the diverse causes of amenorrhea, the relationship
to sexual identity, possible infertility
inform the woman about the purpose of each diagnostic
test
sensitive listening, interviewing, and presenting treatment
options
Nutritional counseling
Emphasize healthy life style
Menstrual Disorders: Amenorrhea | Page 11
12. Amenorrhea: Teaching guidelines for maintaining a
healthy lifestyle
Balance energy expenditure with energy intake
Modify diet to maintain ideal weight
Avoid excessive use of alcohol and mood-altering or sedative drugs
Avid cigarette smoking
Identify areas emotional stress and seek assistance to resolve them
Balance work, recreation, and rest
Maintain a positive outlook regarding the diagnosis and prognosis
Participate in ongoing care to monitor replacement therapy or
associated conditions.
Maintain bone density through:
calcium intake( 1,200-1.5 mg or more daily)
weight-bearing exercise(30 minutes or more daily)
hormone replacement therapy
Menstrual Disorders: Amenorrhea | Page 12
13. Copyright 2013, State of Tasmania. This resource has been developed by
TasTAFE Health Services North. All content in this resource has been
produced by TasTAFE personnel and is made available to you for your
personal research and study. The content in this resource must not be redistributed or copied in any form.
Menstrual Disorders: Amenorrhea | Page 13